CLINICALLY ISOLATED SYNDROME
Clinical trials for CLINICALLY ISOLATED SYNDROME explained in plain language.
Never miss a new study
Get alerted when new CLINICALLY ISOLATED SYNDROME trials appear
Sign up with your email to follow new studies for CLINICALLY ISOLATED SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New study checks MS drug in breastmilk: is it safe for babies?
Knowledge-focused CompletedThis study looked at how much of the multiple sclerosis (MS) drug ocrelizumab passes into breastmilk and whether it affects babies' immune cells (B cells). Twenty-six breastfeeding women with MS or clinically isolated syndrome (CIS) and their healthy infants took part. Researcher…
Matched conditions: CLINICALLY ISOLATED SYNDROME
Phase: PHASE4 • Sponsor: Hoffmann-La Roche • Aim: Knowledge-focused
Last updated May 01, 2026 19:56 UTC
-
New tools aim to spot nerve damage early in MS
Knowledge-focused CompletedThis study followed 134 people with a first episode of neurological symptoms (clinically isolated syndrome) to develop better ways to detect and track nerve damage. The goal is to help doctors decide sooner whether to adjust treatment for those at risk of developing multiple scle…
Matched conditions: CLINICALLY ISOLATED SYNDROME
Sponsor: University Hospital, Lille • Aim: Knowledge-focused
Last updated May 01, 2026 16:00 UTC
-
Pregnancy drug study checks immune cells in newborns
Knowledge-focused CompletedThis study checked how much of the multiple sclerosis drug ocrelizumab passes from mother to baby during pregnancy. Researchers measured B cell levels in 70 infants whose mothers took the drug before or early in pregnancy. The goal was to understand the drug's effect on the baby'…
Matched conditions: CLINICALLY ISOLATED SYNDROME
Phase: PHASE4 • Sponsor: Hoffmann-La Roche • Aim: Knowledge-focused
Last updated May 01, 2026 15:56 UTC